Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | PNLIP | P16233 | 1/20 | 0.46 |
| ▸ | KDR | P35968 | 4/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | FLT1 | P17948 | 1/20 | 0.43 |
| ▸ | CSF1R | P07333 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | STK39 | Q9UEW8 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | GFER | P55789 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7074399 | 0.86 | PNLIP (0.61) | KMT2APNLIPSTK39MEN1MAPK1 | |
| SCHEMBL1457413 | 0.80 | KMT2A (0.52) | KMT2APNLIPKDRHPGDKDM4E | |
| SCHEMBL7556185 | 0.80 | KMT2A (0.47) | KMT2APNLIPKDRHPGDKDM4E | |
| SCHEMBL1457071 | 0.78 | RXFP1 (0.56) | KMT2AHPGDKDM4EHTTMEN1 | |
| SCHEMBL7080494 | 0.78 | PNLIP (0.62) | KMT2APNLIPHPGDKDM4EHTT | |
| SCHEMBL7077257 | 0.76 | RXFP1 (0.60) | KDRSTK39RXFP1 | |
| SCHEMBL7160758 | 0.76 | SMO (0.52) | KMT2AHPGDKDM4EHTTMEN1 | |
| SCHEMBL7073943 | 0.75 | PKM (0.47) | PNLIPMAPK1GFERRXFP1 | |
| SCHEMBL7074417 | 0.73 | TLR8 (0.49) | PNLIPSTK39MAPK1GFERRXFP1 | |
| SCHEMBL2238659 | 0.73 | PGR (0.49) | KMT2APNLIPKDRHPGDHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1533303-B1 | Substituted Aminosalicylacid Amides ( intermediates ) | BAYER CROPSCIENCE AG (DE) | 2013-04-24 | — | — | EP | disclosed |
| EP-1533303-B1 | Substituted Aminosalicylacid Amides ( intermediates ) | BAYER CROPSCIENCE AG (DE) | 2013-04-24 | — | — | EP | disclosed |
| EP-2292608-A1 | Intermediates for the preparation of substituted Aminosalicylic acid amides with fungicidal activity | Bayer CropScience AG (DE) | 2011-03-09 | — | — | EP | disclosed |
| EP-2292608-A1 | Intermediates for the preparation of substituted Aminosalicylic acid amides with fungicidal activity | Bayer CropScience AG (DE) | 2011-03-09 | — | — | EP | disclosed |
| EP-0970057-B1 | SUBSTITUTED AMINOSALICYCLIC ACID AMIDES WITH FUNGICIDAL EFFECT AND INTERMEDIATE PRODUCTS FOR PRODUCTION THEREOF | BAYER CROPSCIENCE AG (DE) | 2006-02-01 | — | — | EP | disclosed |
| EP-1533303-A1 | Substituted Aminosalicylacid Amides ( intermediates ) | Bayer CropScience AG (DE) | 2005-05-25 | — | — | EP | disclosed |
| US-6380386-B2 | INSECTICIDES, BACTERICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2002-04-30 | — | — | US | disclosed |
| US-20020006958-A1 | Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2002-01-17 | — | — | US | disclosed |
| US-6194418-B1 | Substituted aminosalicyclic acid amides with fungicidal effect and intermediate products for production thereof | BAYER AKTIENGESELLSCHAFT (DE) | 2001-02-27 | — | — | US | disclosed |
| EP-0970057-A2 | SUBSTITUTED AMINOSALICYCLIC ACID AMIDES WITH FUNGICIDAL EFFECT AND INTERMEDIATE PRODUCTS FOR PRODUCTION THEREOF | BAYER AG (DE) | 2000-01-12 | — | — | EP | disclosed |
| WO-1998041513-A2 | SUBSTITUTED AMINOSALICYCLIC ACID AMIDES WITH FUNGICIDAL EFFECT AND INTERMEDIATE PRODUCTS FOR PRODUCTION THEREOF | BAYER AKTIENGESELLSCHAFT (DE) | 1998-09-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020006958-A1 | Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof | AADAC, DDC, DAO | KMT2A 1930/4885PNLIP 4717/4885KDR 3411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.